Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-8,853
Closed -$1.05M 15
2025
Q2
$1.05M Buy
8,853
+261
+3% +$32.5K 0.3% 69
2025
Q1
$1.18M Sell
8,592
-161
-2% -$23K 0.27% 76
2024
Q4
$1.34M Sell
8,753
-737
-8% -$124K 0.31% 71
2024
Q3
$1.79M Buy
9,490
+1,558
+20% +$326K 0.42% 63
2024
Q2
$1.84M Buy
7,932
+1,376
+21% +$299K 0.46% 54
2024
Q1
$1.41M Buy
6,556
+2,881
+78% +$675K 0.38% 65
2023
Q4
$951K Buy
+3,675
New +$903K 0.28% 68

Other funds holding BIIB

DOHJ LLC's BIIB Position: Q3 2025 in Review

DOHJ LLC sold out of Biogen (BIIB) in Q3 2025, closing a stake of 8,853 shares — an estimated $1.05M sold.

DOHJ LLC first reported a position in BIIB in Q4 2023 and held it in 7 quarters. The position peaked at $1.84M in Q2 2024. 905 funds tracked by Wall St. Rank hold BIIB as of Q3 2025.

  • DOHJ LLC reported no remaining Biogen position as of Q3 2025 after selling out during the quarter.
  • DOHJ LLC sold 8,853 Biogen shares in Q3 2025, an estimated $1.05M.
  • DOHJ LLC first reported a position in Biogen in Q4 2023 and held it in 7 quarters.
  • DOHJ LLC's Biogen position peaked at $1.84M in Q2 2024.
  • 905 funds tracked by Wall St. Rank held Biogen as of Q3 2025.

Based on DOHJ LLC's 13F filing for Q3 2025.